Renaissance Technologies’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Renaissance Technologies’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-840,943	Closed	-$145M	–	3574
2015 Q1	$145M	Buy	840,943 +799,524	+1,930%	+$117M	0.31%	39
2014 Q4	$4.76M	Sell	41,419 -3,106	-7%	-$376K	0.01%	1300
2014 Q3	$6.96M	Sell	44,525 -213,294	-83%	-$30.9M	0.02%	991
2014 Q2	$31.8M	Buy	257,819 +167,685	+186%	+$18.5M	0.07%	303
2014 Q1	$9.34M	Sell	90,134 -178,385	-66%	-$18.3M	0.02%	907
2013 Q4	$24.2M	Buy	268,519 +6,419	+2%	+$512K	0.06%	404
2013 Q3	$17.5M	Sell	262,100 -76,219	-23%	-$5.25M	0.04%	529
2013 Q2	$22.4M	Buy	+338,319	New	+$19.3M	0.06%	405

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Renaissance Technologies's SLXP Position: Q2 2015 in Review

Renaissance Technologies sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 840,943 shares — an estimated $145M sold.

Renaissance Technologies first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $145M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Renaissance Technologies reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Renaissance Technologies sold 840,943 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $145M.
Renaissance Technologies first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Renaissance Technologies's SALIX PHARMACEUTICALS LTD DEL position peaked at $145M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Renaissance Technologies's 13F filing for Q2 2015, filed 14 Aug 2015.